Thyrocare Q3: Profit up nearly 37%, EBITDA surges 47%; diagnostics drive margin expansion

Thyrocare Technologies posted a 36.7% net profit jump to ₹26.1 crore in Q3, driven by diagnostics growth, improved margins, and higher revenues. Shares closed 1.01% higher at ₹458.10, ahead of the result announcement.

Leave a Reply

Your email address will not be published. Required fields are marked *